Skip to main content

Top Stories

WVU researcher studies new treatment for pancreatic cancer

One reason pancreatic cancer is so lethal is its resistance to traditional chemotherapy. But West Virginia University surgical oncologist Brian Boone is exploring whether FOLFIRINOX—a new combination of cancer drugs—can improve outcomes in patients whose pancreatic cancer is “borderline resectable,” meaning that a tumor may be too close to a blood vessel to be removed safely.

Find an Expert

Social Media

YouTube

Watch more videos from the official YouTube channel of West Virginia University.

Videos